RAD50 is a potential biomarker for breast cancer diagnosis and prognosis
This study finds RAD50 expression is lower in breast cancer and higher expression is linked to poorer survival, suggesting it as a potential biomarker for diagnosis and prognosis.
Cancer Research and Cellular Therapeutics · Oct 21, 2024Peer-reviewedCancer Biology